Advanced Accelerator Applications USA, Inc. et al v. Lantheus Medical Imaging, Inc. et al
| Advanced Accelerator Applications USA, Inc. and Advanced Accelerator Applications SA |
| Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., Point Biopharma USA Inc. and Point Biopharma Global Inc. |
| 1:2024cv00095 |
| January 25, 2024 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 19, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 22 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 22, 2024 - filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) |
SO ORDERED, re #22 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer or otherwise respond to the Complaint (D.I. 1) to April 22, 2024. Set/Reset Answer Deadlines: Lantheus Holdings, Inc. answer due 4/22/2024; Lantheus Medical Imaging, Inc. answer due 4/22/2024; Point Biopharma Global Inc. answer due 4/22/2024; Point Biopharma USA Inc. answer due 4/22/2024. Ordered by Judge Maryellen Noreika on 3/19/2024. (as)
|
| Pro Hac Vice Attorney Candace Polster for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney David A. Chen for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney Bruce M. Wexler for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney Eric W. Dittmann for Point Biopharma Global Inc. and Point Biopharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Filing 21 Pro Hac Vice Fee - Credit Card Payment received for James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen, and Candace M. Polster. ( re #20 MOTION for Pro Hac Vice Appearance of Attorney James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen and Candace M. Polster )( Payment of $ 250, receipt number ADEDC-4345776).(Tigan, Jeremy) |
| Filing 20 MOTION for Pro Hac Vice Appearance of Attorney James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen and Candace M. Polster - filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) |
| Pro Hac Vice Attorney Jane M. Love for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) |
|
SO ORDERED re #20 MOTION for Pro Hac Vice Appearance of Attorney James P. Leeds, Bruce M. Wexler, Eric W. Dittmann, David A. Chen and Candace M. Polster filed by Point Biopharma Global Inc., Point Biopharma USA Inc. ORDERED by Judge Maryellen Noreika on 2/23/2024. (dlw)
|
| Filing 19 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eli Lilly and Company for Point Biopharma Global Inc., Point Biopharma USA Inc. filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) |
| Filing 18 STIPULATION TO EXTEND TIME for Defendants POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer, or otherwise respond to the Complaint (D.I. 1) to March 21, 2024 - filed by Point Biopharma Global Inc., Point Biopharma USA Inc.. (Tigan, Jeremy) |
|
SO ORDERED re #18 STIPULATION TO EXTEND TIME for Defendants POINT Biopharma USA Inc. and POINT Biopharma Global Inc. to move, answer, or otherwise respond to the Complaint (D.I. 1) to March 21, 2024 (Set/Reset Answer Deadlines: Point Biopharma Global Inc. answer due 3/21/2024; Point Biopharma USA Inc. answer due 3/21/2024). ORDERED by Judge Maryellen Noreika on 2/20/2024. (dlw)
|
| Filing 17 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Lantheus Holdings, Inc.; Corporate Parent Lantheus Holdings, Inc. for Lantheus Medical Imaging, Inc. filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Wilson, Samantha) |
| Filing 16 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. to move against, answer, or otherwise respond to the Complaint to March 21, 2024 - filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Gaza, Anne) |
|
SO ORDERED re #16 STIPULATION TO EXTEND TIME for Defendants Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. to move against, answer, or otherwise respond to the Complaint to March 21, 2024 (Set/Reset Answer Deadlines: Lantheus Holdings, Inc. answer due 3/21/2024; Lantheus Medical Imaging, Inc. answer due 3/21/2024). ORDERED by Judge Maryellen Noreika on 2/15/2024. (dlw)
|
| Pro Hac Vice Attorney Robert W. Trenchard for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorneys John C. Rozendaal, Dennies Varughese, and Alexander V. Alfano for Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
|
SO ORDERED re #14 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc. ORDERED by Judge Maryellen Noreika on 2/9/2024. (dlw)
|
| Filing 15 Pro Hac Vice Fee - Credit Card Payment received for Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano. ( re #14 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano )( Payment of $ 150, receipt number ADEDC-4334186).(Gaza, Anne) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., J.C. Rozendaal, and Alex Alfano - filed by Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc.. (Gaza, Anne) |
| Pro Hac Vice Attorney Katherine M. Worden for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorney Andrew P. Blythe for Advanced Accelerator Applications SA and Advanced Accelerator Applications USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 13 Pro Hac Vice Fee - Credit Card Payment received for Katherine Worden. ( re #12 MOTION for Pro Hac Vice Appearance of Attorney Katherine Worden )( Payment of $ 50, receipt number ADEDC-4330470).(Silver, Daniel) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Katherine Worden - filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Attachments: #1 Certification for Katherine Worden)(Silver, Daniel) |
|
SO ORDERED re #12 MOTION for Pro Hac Vice Appearance of Attorney Katherine Worden filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. ORDERED by Judge Maryellen Noreika on 2/5/2024. (dlw)
|
|
SO ORDERED re #10 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. ORDERED by Judge Maryellen Noreika on 2/2/2024. (dlw)
|
| Filing 11 Pro Hac Vice Fee - Credit Card Payment received for Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe. ( re #10 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe )( Payment of $ 150, receipt number ADEDC-4328535).(Silver, Daniel) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Jane M. Love, Robert W. Trenchard, and Andrew P. Blythe - filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (Silver, Daniel) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 9 SUMMONS Returned Executed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA.Point Biopharma Global Inc. served on 1/29/2024, answer due 2/20/2024. (Silver, Daniel) |
| Filing 8 SUMMONS Returned Executed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA.Point Biopharma USA Inc. served on 1/29/2024, answer due 2/20/2024. (Silver, Daniel) |
| Filing 7 DECLARATION of Service of Complaint and related papers on Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. (Silver, Daniel) Modified on 1/31/2024 (dlw). |
| Filing 6 Summons Issued as to Lantheus Holdings, Inc. on 1/25/2024; Lantheus Medical Imaging, Inc. on 1/25/2024; Point Biopharma Global Inc. on 1/25/2024; Point Biopharma USA Inc. on 1/25/2024. (Attachments: #1 Summons Issued, #2 Summons Issued, #3 Summons Issued) (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,596,276. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/12/2023. Date of Expiration of Patent: 07/25/2038.Thirty Month Stay Deadline: 6/12/2026. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Lantheus Holdings, Inc., Lantheus Medical Imaging, Inc., Point Biopharma Global Inc., Point Biopharma USA Inc. ( Filing fee $ 405, receipt number ADEDC-4322133.) - filed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications SA. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
